PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-0.04%
Both yoy net incomes decline, with BB at -465.22%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
6.34%
Some D&A expansion while BB is negative at -2.00%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
-417.65%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
-2.62%
Negative yoy SBC while BB is 22.22%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
139.11%
Well above BB's 118.60% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
107.24%
AR growth well above BB's 193.33%. Michael Burry would fear inflated sales or less stringent credit controls vs. competitor.
-141.75%
Both reduce yoy inventory, with BB at -100.00%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
2424.24%
AP growth well above BB's 100.00%. Michael Burry would be concerned about potential late payments or short-term liquidity strain relative to competitor.
151.29%
Growth well above BB's 20.00%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
0.85%
Lower 'other non-cash' growth vs. BB's 441.18%, indicating steadier reported figures. David Dodd would confirm no missed necessary write-downs or gains.
77.21%
Some CFO growth while BB is negative at -3.23%. John Neff would note a short-term liquidity lead over the competitor.
-21.92%
Negative yoy CapEx while BB is 10.00%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
-1710.12%
Both yoy lines negative, with BB at -12.50%. Martin Whitman sees an overall caution or integration phase for both companies’ expansions.
-21.75%
Both yoy lines negative, with BB at -2042.86%. Martin Whitman would suspect an environment with fewer attractive securities or a strategic pivot to internal growth.
18.13%
We have some liquidation growth while BB is negative at -89.12%. John Neff notes a short-term liquidity advantage if competitor is holding or restricted.
22.32%
Growth well above BB's 12.50%. Michael Burry would suspect heavier intangible or side spending overshadowing competitor’s approach, risking short-term FCF.
-480.23%
Both yoy lines negative, with BB at -181.54%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
84.62%
Debt repayment growth of 84.62% while BB is zero at 0.00%. Bruce Berkowitz sees a mild advantage that can reduce interest costs unless expansions demand capital here.
31.13%
Lower share issuance yoy vs. BB's 100.00%, implying less dilution. David Dodd would confirm the firm still has enough capital for expansions.
-6.04%
We cut yoy buybacks while BB is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.